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Physicochemical aspects of urolithiasis
BIRDWELL FINLAYSON
Division of Urology, Department of Surgery, University of Florida, College of Medicine, Gainesville, Florida
The following discussion centers on calcium oxa-
late and calcium phosphate stones, but permits gen-
eralization to other forms of stone. Although it con-
stitutes a primer on the subject, it does attempt to
deal with inconsistencies in our current meager
knowledge of the physical characteristics of uro-
lithiasis. In addition, it describes concepts and ap-
proaches that appear to be useful and that should be
incorporated into urolithiasis research, to make fu-
ture work in the field susceptible to analysis by
conventional physical theory.
The known physicochemical features of uro-
lithiasis are readily divided into four interrelated sub-
jects: the driving force (supersaturation), nucleation,
the growth of crystals and particles, and aggregation.
The chemical driving force, urinary supersaturation
Supersaturation of urine with respect to the salts
that stones will or do consist of gives rise to the
thermodynamic driving force for the formation of
stones. This driving force, expressed as free energy
(AG), is given by
= RT ln (),
where R is the gas constant, T is the temperature,
and A1 and A0 are the activities of the unionized salt
species in solution at any given condition and at
equilibrium, respectively [1]. Activity (A) is related
to concentration (C) through an activity coefficient
(1) by
A = fC. (2)
When urine is such that, for a given stone salt, A1/A0
< 1, then G < 0, the urine is said to be undersatu-
rated with respect to the stone salt, and any stones
that are present can dissolve [2, 3]. As an example,
treatment with allopurinol causes A1/A., to be less
than 1 with respect to uric acid, and it is common for
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uric acid stones to dissolve in this circumstance.
When urine is such that, for a given stone salt, A1/A0
= 1, then zG = 0, and the urine is said to be
saturated. In this circumstance, old stones will not
dissolve, and new ones will not form; but old stones
can grow, in the sense that aggregation of pre-exist-
ing stones can occur. When, for a given stone salt,
AIA0 > 1, then G > 0, and the urine is said to be
supersaturated. In this circumstance, there is availa-
ble free energy; if stones are present, they may grow,
but if stone crystals are not present, then precipita-
tion will not occur, unless A1/A0 exceeds an experi-
mentally ill-defined limit called the "metastable
limit." Above the metastable limit, it is possible both
for new stones to form and for old stones to grow
(Fig. 1).
Inasmuch as the progress of stone disease is gov-
erned by the available free energy, it is important to
have a quantitative measure of A1/A0; it makes it
possible to identify people who have an increased
likelihood of stone disease and to monitor the effec-
tiveness of the anti-stone therapies that operate by
reducing A1/A0, such as magnesium oxide, hydro-
(1) chlorothiazide, and cellulose phosphate. In principle,
there are a variety of methods for measuring A11A0,
but during the last 10 years only three have received
persistent attention. Calculation of A1/A0 was pop-
ularized by Robertson [41!. Pak and Chu [5] have
described a semi-empirical equilibration technique
that capitalizes on the linear relations among the
urinary concentrations of calcium, phosphate, and
oxalate. In general, the relations used by Pak and
Chu are nonlinear; but in the range of change en-
countered during calcium oxalate or calcium phos-
phate precipitation in urine, the expected error of a
linear assumption is less than 2%, as judged by the
ab initio calculations. Gill, Silvert, and Roma have
introduced a radionuclide tracer into the Pak
method, to simplify chemical quantitation [6]. With a
firm grasp of the ab initio calculations, a theoretical
understanding of the methods of Pak and Gill will
appear elementary.
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Fig. 1. A mechanical analogy of chemical metastability. The
vertical bars represent concentrations of a precipitable salt. The
available thermal free energy is sufficient to cause fluctuations that
tip the bars about the pivot point (P) through angular displacement
(0). When the center of mass (C) is displaced (C') lateral to P, the
mechanical bar will fall over, which is equivalent to precipitation.
In the region of undersaturation, the bar cannot be toppled by
fluctuations equal toO. In the region of metastable supersaturation,
catalytic surfaces can augment the fluctuations so that C' is dis-
placed lateral to P. This case is equivalent to crystal growth or
heterogeneous nucleation. In the region of unstable supersatura-
tion, thermal concentration fluctuations, 0, are sufficient to place
C' lateral to P and cause the bar to fall over, which is analogous to
spontaneous precipitation.
Ab initio calculations of A,1A0. Urine is a solution
containing a set of cations (C) and a set of anions (A).
Some of the cations and anions will very rapidly
(relaxation time, 1O see) undergo ion complex
formation
Ck + A3 CAk,).
For each complex formed, the equilibrium is gov-
erned by the mass action relation,
Kk,3 = [CAk,3]fk,j/[Ck][A3]fkfJ,
where Kk, is the stability constant for the (k,j)th
complex, f is the activity coefficient for the n1
charged species, and brackets indicate concentra-
tion. If [TCk] is the sum of the concentrations of all
species containing Ck, then conservation of mass
requires that
[TCRI = [C3] +,
ma
and IITA3] = [As] + [CAk,J]nk,3,J.
+ [CA,](Z)2, (8)
k=j=1
with R, S, U, and V as the numbers of the species
being summed. In practice, to make an ab initio
calculation, urine is analyzed for pH and total so-
(3) dium, potassium, calcium, magnesium, ammonium,
sulfate, phosphate, citrate, oxalate, urate, and chlo-
ride, and the calculation is made with Equations 5—8.
There are far too many equations to attempt such a
calculation for urine by hand. A number of computer
programs, however, have been written and can be
obtained from their authors''. (The interested
reader will find a step-by-step guide through the ab
initio calculation presented elsewhere [7]).
Working with urine at 25°C, Robertson [4] showed
a high degree of correlation between ab initio calcu-
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In Equations 5a and Sb, m is the number of possible
complexes, and nk,,1 is the stoichiometric number of
the 1th species in the (k,j)th complex. The stoichio-
metric number is required for polynuclear com-
plexes, such as CaaCa O42Equation 5a transforms to
[CE] = [TCE]/(1 + ,[CAk,3]nk,3,k). (6)
Equation Sb undergoes a similar transformation.
Equations of the genre of Equation 4 can be substi-
tuted into Equations 5a and 5b, giving a set of nonlin-
ear simultaneous equations in [TCE], [TA3], [CE],
and [A3], whose solution rapidly converges to self-
consistency by iterative approximation. In my labo-
ratory, it was found empirically that in most urines
the activity coefficient, f, can be taken to be O.732,
with Z being the electronic charge of the species in
question. Alternatively, f at 38°C can be calculated
with
= exp(— 1 .202Z2ft.Jw/( 1 +°.Jw)) —0.285w)). (7)
Equation 7 is the Davies modification of the Guggen-
heim approximation of the Debye-HUckel first-order
solution of the Poisson-Boltzman equation for the
energy of the electrostatic field of an ion in ionic
solution [2], in which w is the ionic strength given by
2w = [Ck](Zh)2 +
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lated and experimentally measured calcium concen-
tration, [Ca2]. Robertson's early ab initio calcula-
tions used an inappropriate stability constant for
calcium oxalate that necessarily gave an appreciable
error in the calculated activity of A1(CaC2O4). But
approximately the same fractional error occurs in the
calculated value of A0(CaC2O4); thus, whenever
Robertson's calculations for calcium oxalate are pre-
sented as A1/A0 (i.e., relative supersaturation), the
estimates are reasonable from a theoretical point of
view. In recent calculations, Robertson et al has
used a calcium oxalate stability constant of 1,900 M'
[8]. It is not clear whether his current program has
been altered for 38°C. In my laboratory, using a 38°C
program and a calcium oxalate stability constant of
2,746 M1 [91, we are able to calculate the equilib-
rium value of calcium oxalate precipitating from arti-
ficial urine to within 20%. Ab initio calculations of
A1/A0 for wheweilite do not agree well with the re-
suits of the semi-empirical methods to be discussed
later; however, if for no other reason, ab initio calcu-
lations are useful because they provide an incisive
technique for investigating the semi-empirical
methods.
In an effort to reduce the number of chemical
analyses needed for the ab initio calculation of uri-
nary supersaturation, Marshall and Robertson have
empirically analyzed the results of their ab initio
calculations of urinary supersaturation and have de-
vised nomograms for estimating supersaturation with
considerably fewer chemical analyses [10]. Only the
chemical determination of citrate and oxalate pose a
problem in practice. The nomogram approach ob-
viates the citrate determination and access to a
computer.
Semi-empirical method of Pak and Chu. In the
method of Pak and Chu [5], the concentration of
dissolved stone salt is measured before and after
equilibration with solid stone salt. Relative super-
saturation, A1/A0, for whewellite is calculated with
A1/A0 =
[TCa1][(TC204,1)[ (f1)8[TCa0] [TC2O4)0](f0)8.
Pak and Chu have devised an approximation to esti-
mate f, and I. Detailed calculations, however, show
thatf1 differs from f, by <0.001; thus, as noted,
and can be ignored because they cancel in Equation
9. The major innovations in the Pak and Chu method
are the disregard of the complexing of the precipitat-
ing ions that occurs with calcium, phosphate, and
oxalate in urine and urine-like solutions and the use
of total concentrations, instead of ion concentra-
tions, in calculating A11A0 with Equation 9. An exam-
ination of four calculations on urine, randomly se-
lected from our archives of calculations, showed that
the average A11A0 for whewellite calculated by Equa-
tion 9 is 2.4 1.2% greater than that generated by
the ab initio calculation. This small error is expected
in estimates of AIA0 resulting from the use of Pak
and Chu's approximations and is quite acceptable.
The preceding theoretical comments made about
the semi-empirical estimation of A11A0for whewellite
also apply to Pak and Chu's method for determining
brushite A11A0. It is worth noting, however, that the
trouble Pak and Chu take in calculating [HPO421
from total phosphate concentration and pH can be
neglected. Under their assumptions, Equations 4 and
Sb require that [HPO42] [aTPO4II. If the pH is
constant, a is constant and will cancel out when
Equation 9 is used for calculating A1/A0; see Equa-
tion 9 and replace [TC204] with [HP042-]. If pH1
pH0 then a is not constant; but the semi-empirical
method is then not valid for phosphate precipita-
tions. The correspondence between ab initio and
semi-empirical estimates of brushite A1/A0 is good
[11]. Parenthetically, although the calculation is triv-
ial, ab initio estimates of A1/A0 for uric acid agree
well with semi-empirical estimates by Pak et al [121.
The fundamental conceptual problem in compar-
ing the ab initio calculation and the semi-empirical
equilibration method is that the former does not
calculate A0 but rather uses a thermodynamic A0 that
has been extensively characterized in simple
aqueous solutions. The semi-empirical equilibration
technique uses an A0 developed by experimental
observation on urine. Ab initio calculated (A1/A0)' s
for calcium oxalate in urine are two to three times
greater than the (A11A0)'s generated by the Pak et al
method 111], a distressing disparity. I hasten to point
out the ab initio calculation appears to be capable of
calculating A1. Robertson has shown good corre-
spondence between calculated and measured [Ca2i
in urine [4]. And we have been able, in my labora-
tory, to predict, to within 20%, the experimentally
(9) measured A0 in artificial urine that contains no crys-
tal-growth inhibitors, such as pyrophosphate and
macromolecules. Ab initio calculations have a
proven record of utility in other systems.
One possible explanation of the differing results
produced by the two methods with urine is that they
use different estimates of A. This line of reasoning
requires that the thermodynamic A0 be less than the
A0 empirically measured in urine. It may be specu-
lated that the empirically measured A0 is larger than
the thermodynamic A0 because of crystal-growth in-
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hibitors in urine. This speculation, which remains
untested, arises from observations that crystals cov-
ered with a film of inhibitor will not continue to grow
when A > A, > A0, in which A is a critical concen-
tration and by empirical testing would appear to be
A0 [13]. Ohata and Pak [14] have shown that ethane-
1-hydroxyl- 1 ,2-diphosphonate, a crystal-growth, in-
hibitor, gives an apparent A0 greater than the ther-
modynamic A<, with brushite. In support of this con-
cept, there is some evidence that the use of a large
excess of the solid salt yields an empirically derived
A0 that closely approximates the thermodynamic A0
[15]. Another possible explanation of the difference
between the ab initio and semi-empirical estimates
of whewellite supersaturation in urine is that unap-
preciated urinary chelators of oxalate, such as
spermine, may be present in sufficient concentration
to invalidate the ab initio calculations. A third possi-
ble explanation for the difference is that true equilib-
rium was not obtained in the semi-empirical method.
A critical evaluation of the approach to equilibrium
with the semi-empirical method has not yet been
published.
Semi-empirical method of Gill, Silvert, and Roma
[6]. The method of Gill et al has been applied thus
far only to whewellite AIA0 estimation. The method
differs from Pak and Chu's method [5] in that an
oxalate tracer (14C) is added to the system, and only
changes in the oxalate concentration are measured.
Ab initio calculations in my laboratory on four ran-
domly selected urine samples showed that setting
[TCa1] = [TCa0II leads to an average error of 3.7
2.0% in estimating A11A0 with equation 9, which is
acceptable.
The primary drawback to the Gill et al method is
that solid-state diffusion of '4C-oxalate into the seed
crystals of whewellite is appreciable and makes the
method theoretically valid only at the limit of no seed
crystals. That theoretical restriction is experimen-
tally implemented by minimizing the amount of seed
crystals; this in turn increases the system's relaxa-
tion time and thereby increases uncertainty about the
experimental estimate of A0. In a study of 23 urine
samples that correlated equilibrium calculations of
A1/A0 with estimates by the Gill et al method, the
correlation coefficient was 0.86 [16]. The apparent
problem of estimating A0 for CaC2O4 H20 that is
intrinsic in the Pak and Chu method also applies to
the Gill method.
A comment on the usefulness of AIA0. The estima-
tion of A11A0, by whatever method, is clinically use-
ful. Such estimations are an extension of the same
reasoning that prompts measurement of 24-hr un-
nary calcium by those who do not comprehend the
pervasive nature of the second law of thermodynam-
ics. Estimates of A1/A0, used in cluster analysis in
conjunction with estimates of urinary-aggregation in-
hibitor concentrations, have been used to distinguish
stone-formers from non-stone-formers [8]. Because
crystal-growth inhibitor activity is often correlated
with aggregation inhibition, the successful use of
aggregation inhibition in the cluster analysis may be
due to the inhibitor altering A0 instead of a direct
effect on aggregation. Further experimental work is
needed to resolve the true significance of aggregation
inhibitor in the analysis of clustering with A1/A0
estimates.
The potential efficacy of antistone therapy has
been evaluated by A/A0 estimates [17, 18]. In the
case of calcium oxalate, the semi-empirical method
is probably more valid, and its use is recommended
until a better concordance can be made between
calculated and measured A11&.
It has been experimentally established that stone-
formers' urine is supersaturated with the salt of the
stone that they are growing [9, 19]. The conceptual
problem is that some non-stone-formers' urine at
times seems to be just as supersaturated as urine
from stone-formers, but they fail to form stones. The
difference must lie in the boundary conditions, the
stochastic nature of the process, or urinary inhibitors
of nucleation, crystal growth or aggregation, or some
as yet undiscovered principle.
Nucleation
Nucleation is the initial event in a phase transfor-
mation (e.g., stone-salt precipitation). Except near
the spinodal (defined below) where kinetic consider-
ations may take precedence, the onset of nucleation
is governed by the energy given up in forming a new-
phase volume (G) and by the energy required to
form the surface of the new phase [1, 20]. If the new
surface is well-defined in space, the situation is class-
ical, and the associated surface energy is the familiar
liquid-solid interfacial tension (o). If the surface of
the nucleus is diffuse, however, the situation is non-
classical and the surface energy is related to the
energy required to form a gradient between the bulk
of the two phases [21]. A relatively recent and reada-
ble exposition of the physical chemistry of nuclea-
tion in liquids and solution has been written by Wal-
ton [22]. The following brief discussion of nucleation
develops points of view that have been neglected in
the literature on urolithiasis, but that can and should
be experimentally pursued in current stone research.
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Classical homogeneous nucleation. As with most
physicochemical processes, we start with free-en-
ergy considerations. The standard free-energy
change (G°) resulting from the formation of a spher-
ical new phase can be written as
= + Fci,
in which I is the sphere diameter. If / is too small, the
surface-energy term prevails, and the new phase will
dissolve. If I is large enough, the volume-energy
term prevails, and the new phase will either stay the
same size or grow. The critical value of 1(1*), needed
for a new particle to remain stable or grow, is given
by
1* = 4ciIzG. (11)
In principle, ci can be calculated, but in practice, it
is usually experimentally measured. However,
=
—mkT
in(S), (12)
in which m is the number of ions in the neutral
molecule, v is the molecular volume, k is the Boltz-
mann constant, T is absolute temperature, and A1!A0
is denoted as S to simplify the notation (Fig. 2).
0
x
0)
Co
C)
0)
0C
w
— 16Hcr32zG* = _________
3(mkT lnS*)2
= 4)ciS/(lnS*)2 (14)
(10) with 4) defined by Equation 13. Because G* is
equivalent to an activation energy, the rate of nuclea-
tion (J) is written as
J = Fexp(_G*IkT),
or J = Fexp(4)ciSIkT(lnS*)2).
The value of F is not known with certainty, but is
usually taken to be 10 to 1082.
S', the metastable limit, can be experimentally
measured in two ways. In the first, J is measured as a
function of S. Because it is virtually impossible to
prepare solutions that are free of particulate matter
that acts as sites of heterogeneous nucleation at S <
Sn', J increases perceptibly with S; but in the region
of S*, dJIdS abruptly changes from --0 to a large
positive value. The position of the discontinuity of
dJ!dS on the S axis is an estimate of S*. Alterna-
tively, the mean particle size resulting from a burst of
precipitation increases as S increases and goes
through a maximum at S*. By measuring S' and J,
the values of ci, G*, and 1* can be calculated from
Equations 11, 14, and 16, respectively. It is in this
fashion that many of the estimates of ci used in
discussing nucleation theory have been obtained.
This experimental approach has been used with cal-
cium oxalate. It was found that S* = 31, a- = 67 erg!
cm2, and I = 1.3 nm [20]. Other stone salts have not
been studied in this manner.
Classical heterogeneous nucleation. Heteroge-
neous nucleation occurs when a foreign surface re-
duces the metastable limit by catalyzing nucleation.
Theories of heterogeneous nucleation usually start
with the theory of homogeneous nucleation, outlined
above, and proceed both to modify the activation
free energy, zG*, and increase the pre-exponential
term by --108 [20]. As discussed by Turnbull and
Vonnegut [23], if the nucleus forming on a catalyzing
surface is a sector of a sphere, then a contact angle
(0) can be defined, such that
0 = cos'{ (crc — )!cr1 }, (17)
in which n refers to nucleus, c to catalyst, and I to
liquid (Fig. 3). If G* is the catalyzed activation
energy, then
with
= G*f(0), (18)
f(0) = (2 — cos0)(1 — cosO)214.
Equation 18 indicates that the free-energy barrier to
If G* is zG°, evaluated at h.G°I8l = 0, then the
Equation 11,
(13)
(15)
(16)
5
—5
—10
Diameter, nm
Fig. 2. Calculated energy changes in the Jbrmation of a homoge-
neous nucleus of calcium oxalate. Energy change was calculated
with Equation 10. G, was calculated with Equation 11. The
critical radius (/*) was 1.3 nm, surface energy (cr) was 67 erg/cm2
[201. The point P is 1*. The energy change associated with point P
is equivalent to the energy required to laterally displace the center
of mass C in Fig. I to be over the pivot point. Past point P,
increasing the nucleus diameter causes a negative energy change,
and hence, continued growth of the nucleus is spontaneous.
(19)
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heterogeneous nucleation is reduced by a factor that
is a function of the affinity of the nucleus for the
catalytic surface.
It is well established that potent nucleation cata-
lysts have crystal planes with lattices whose dimen-
sions are similar to the dimensions of a low-index
plane of the crystal that is being nucleated. Indeed,
Lonsdale [241 caused considerable excitement in
stone research when she published a list of low-index
lattice dimensions for stone crystals. Many good
matches were evident. However, because of the
strain energy in a newly formed nucleus that results
from a less-than-perfect lattice match, the goodness
of a lattice match, by itself, is not a reliable predictor
of the nucleation potency of a surface. Matching of
crystal lattices and strain energy do not appear ex-
plicitly in Equation 18, so we will briefly consider
how these physical constraints can be incorporated
into nucleation equations. Consider a catalytic crys-
tal plane with lattice parameter (a) nucleating a crys-
tal plane with lattice parameter (a)0. The degree of
mismatch (6) is
6 = ((a) — (a) )I(a)
and the resulting lattice parameter (x) for the strained
nucleated crystal at the catalytic interface will be a
compromise between (a) and (a)0. The strain (E) in
the new crystal is
(x — (a)I(a), (21)
such that 6. The actual disregistry (D) between
the nucleated crystal and the catalytic surface is
D = 6—
With this construct, the surface energy for the inter-
face between the nucleus and the catalyst is written
as
= y + aD, (23)
in which y is an interaction term determined by
physicochemical factors and aD is a structural term
proportional to the crystal-lattice dislocation density
in the developing nucleus. The heterogeneous-nu-
cleation equation analogous to Equation 17 is
cosO = {cr1 — y — aD} in (24)
It follows that the equation analogous to Equation 10
is
LG = V(LGV + Ce2) + 211r2(1
— cosO)cr1 + 11r2(1 — cos20)(cr — cri), (25)
in which V is the volume of the sector and Ce2 is the
strain-energy density, with C expressed in terms of
elastic coefficients of the newly forming crystal.
Maximizing Equation 16 with respect to nuclear ra-
dius gives an equation analogous to Equation 14:
= 4ll(crt)3(2 + cosO)(1
— cosO)2/3(G + Ce2)2. (26)
Eliminating from Equation 26 gives
= lla2cr,62(1 — GIC62)/{Gr + C62(1
— (1 — GIC62)112)}. (27)
The nucleation potency (P) of a catalyst is propor-
tional to 1I(/3cr, — a6), with /3 = 1 — (o- —
The validity of Equation 27 in predicting the effi-
ciency of heterogeneous-nucleation catalysis in
stone-salt precipitation has not been tested experi-
mentally. In practice, it is thought that 6 usually
needs to be less than 0.1 for P to be large, although
one case of good catalysis of nucleation with 6 — 0.5
has been reported [23]. It is noteworthy that many
instances of 6 < 0.1 can be found in the list of stone-
salt lattice parameters provided by Lonsdale [24].
Classical coherent (epitaxial) vs. noncoherent nu-
cleation. When 6 is small, nucleation is said to be
coherent. When 6 is large, but the surface has high
catalytic potency because /3 is large, nucleation is
noncoherent. "Epitaxial nucleation" has been com-
monly used recently in discussions of precipitation in
biologic systems. There is growing support, how-
ever, for the belief that epitaxial nucleation occurs on
surface defects that have catalytic potency, and once
the nucleus is established, it migrates to the bulk
surface, where it may proceed with oriented (epitax-
Ia!) overgrowth [22, 251.
'22 Other models of nucleation have been proposed,
of which many are variations of the nucleation
schemes that have been discussed here. A major
exception to this generalization is the formulation of
Nielsen [1], who treats nucleation rate as a chemical
reaction and uses his experimental observations
(light-scattering) to compute reaction orders, many
of which are nonintegral.
Nonclassical nucleation: a) Spinodal decomposi-
tion. Many urinary stones and crystallurias contain
Liquid phase (1)
UIn
Heterogeneous nucleating surface (ci
Fig. 3. Schematic view of a drop heterogeneously nucleating at a
liquid-solid interface. The n-s indicate site of surface energy.
(20)
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numerous spherulitic particles [26]. Spherulitic
growth is not predicted by classical-nucleation equa-
tions. One theory that has been advanced to explain
the spherulitic growth holds that because spherulitic
growth systems are multicomponent systems, have
small coefficients of self-diffusion, and crystallize
slowly, plane crystal faces in these systems suffer
instabilities of profile, which give rise to noncoherent
bundles of fibers. The fiber width is the ratio of the
self-diffusion coefficient to the crystal growth rate
[27].
Another approach to spherulitic growth is that of
Cahn and Hilliard (discussed by Uhlmann and Chal-
mers [281), who have taken a very general approach
to nucleation in solid solution and formulated the
nucleation free-energy change in a system, as
= f[g(s) + K(VS)2]dv,
Jv (28)
in which S is relative supersaturation.
Equation 28 is seen to be analogous to Equation
10, in that g(S) is equivalent to Actually, g(S) is
the average for the system. K(VS)2 is equivalent
to the surface-energy term in Equation 10. The 'sur-
face energy," however, is proportional to the square
of the concentration gradient.
Following the suggestion by Sears [21], we now
observe how Equation 28 can be used to make some
qualitative statements about nucleation. A plot of
versus S shows a point of inflection at 32GI
3S2 = 0. The locus of points (S) at various tempera-
tures at which the second derivative of G with re-
spect to S equals zero is called the "spinodal."
When S < S, the system is stable with regard to low-
amplitude thermal fluctuations in concentration; i.e.,
if a large concentration gradient does not occur, then
precipitation will not occur. This is the classical
situation. However, if S > S, then the system is
liable to undergo precipitation in the presence of low-
amplitude thermal fluctuations in concentration. This
is the nonclassical case. Another qualitative distinc-
tion demarcated by the spinodal is that as the nu-
cleating supersaturation increases, when S < S the
radius (r) of the resulting nucleus decreases, whereas
when S > S, the radius of the resulting nucleus
increases with nucleating concentration. The in-
crease in radius is due chiefly to the formation of a
thick diffuse nuclear boundary. Recall that, for the
classical case, Equation 11 states that zG* =2Ir*.
Equation 11 imposes a relationship between
and r* that must be obeyed, if there is to be classical
nucleation. That is, as G* becomes large, r* be-
comes small, and vice versa. Because Equation 12
says that G* = (mkT . lnS*)Iv, r* becomes small
as S* becomes large. Consider, however, the radius
of a nucleus to be composed of two parts: a central
part with radius r0 and a diffuse boundary part T0, so
that r* = r0 + T0. Thus, as T increases in size, the
gradient of S between the solution and the r0 part of
the nucleus becomes smaller. in Equation 28
can, therefore, be made smaller at large supersatura-
tions by building a nonclassical large nucleus with a
diffuse boundary that has a small concentration gra-
dient. Combining Equations 11 and 12 gives
S = exp(2v/(mkTr*)). (29)
Equation 29 says that, for a given nuclear radius, if
the experimentally measured S is greater than pre-
dicted, the situation is no longer classical. Alterna-
tively, at supersaturations greater than 5*, Equation
29 predicts a nonclassical nucleus, inasmuch as the
radius will be bigger than r*. When the nucleus
becomes larger than the classical size, part of its size
consists of its diffuse boundary. The thicker the
boundary, the smaller the gradient, VS. and the gra-
dient energy. Therefore, as S becomes large, it be-
comes energetically economical to form a nucleus
that is nonclassical. The nonclassical nucleus has a
disordered interior; it can be spherulitic, polymicro-
crystalline, or glassy [211. Nonclassical nucleation of
the type under discussion (spinodal decomposition),
is commonly seen in metals and polymer solutions.
Indeed, it is said that because of the relatively large
lattice units of polymer crystals, it is difficult to
obtain the classical type of nucleation in polymer
solutions. A direct demonstration of spinodal decom-
position in aqueous electrolyte solutions has not
been made. Garten and Head [29], however, con-
cluded from a study of crystalloluminescence that
soluble and poorly soluble salts first precipitate as
glassy objects that undergo a solid-state phase trans-
formation to crystallinity. They were able to observe
the transformation because crystalloluminescence
can be electronically detected. Crystallo-
luminescence is a phenomenon that is consistent
with a spinodal decomposition type of nucleation.
Nonclassical nucleation: b) Secondary nucleation.
Chemical engineers have recognized that when a
crystal surface is contacted by a solid object, such as
another crystal, one or more nuclei can be produced.
The production of nuclei is directly related to the
energy of the contact. This is a significant considera-
tion in a commercial crystallization process. In urine,
however, where the concentration of crystals is
around 104/ml or less [30], it is likely that secondary
nucleation plays a small role. For example, when 2-
sm whewellite particles impact at a relative velocity
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of 10 mph (447 cmlsec), the kinetic energy of the
contact is less than 10 erg, which should yield less
than l0 nuclei per contact if the contact area is 1-
sm2 [311. Collision theory predicts that if there are
l0 particles/mi with 20-jsm diameters, randomly
moving at 5 mph, there should be less than 2 x i0
collisionl(m1 sec) [321. Therefore, it is expected
that fewer than 300 secondary nucleations occur
each day—less than one ten-thousandth of the nuclea-
tion activity occurring in urine when l0 particles!
day are being passed. With this analysis, it is ex-
pected that the secondary-nucleation rate would
vary with the square of the number of particles. If the
primary-nucleation rate increases by a factor of lQ,
the ratio of secondary to primary nucleation ap-
proaches unity.
Current knowledge about nucleation of stone salts
and its relevance to urolithiasis. Unless extraordi-
nary precautions are made, most clean solutions con-
tain 106 to 10 submicroscopic particles per milliliter
[201. Many of these particles have high catalytic
potency for nucleating precipitation of a variety of
salts, including stone salts. Therefore, it is custom-
ary not to expect homogeneous nucleation in a pre-
cipitation system, unless the concentration of precip-
itated particles is greater than 106/mi.
Robertson [301 has reported that crystal particle
counts in urine of stone-formers are about 106/mi,
compared with the 106 criterion that has been sug-
gested for homogeneous nucleation [22]. As pointed
out by Trump, Dees, and Kim, urine is rich in cellu-
lar debris that probably can catalyze nucleation [331.
Therefore, it should be tentatively concluded that
most, if not all, stone-salt nucleations in urine are
heterogeneous or nonclassical, or both.
Malek and Boyce have hypothesized that crystal-
line urinary-stone nuclei are manufactured in renal
tubular cells and are extruded into urine [34]. There
is no information on the formation of these hypothe-
sized nuclei. But for the purpose of this discussion,
the process suggested by Malek and Boyce [34] can
be considered another case of either nonclassical or
heterogeneous nucleation.
Nielsen [351 has shown that in filtered solutions of
poorly soluble salts, the induction time for precipita-
tion (r) obeys
T = gC,
in which C is the square root of the molar ion con-
centration product of the precipitating salt and g and
n are empirical constants. For calcium oxalate at
25°C, g = 1.03 x 10 sec, and n = —3.33. According
to this, the lower limit for the induction period for
concentrated urine (C = 1.70 x l0 M) is —2.9 mm,
which is well within the transit time across the kid-
ney. Even though the solutions that Nielsen used
were filtered, we must assume in this case, in the
absence of evidence to the contrary, that the nuclea-
tion was heterogeneous, which is also probably the
case in urine.
Robertson, Peacock, and Nordin have measured
the S that gives a perceptible precipitation in 15 mm
at 25°C for various stone salts [19]. No serious at-
tempt to determine whether these precipitations re-
sulted from homogeneous or heterogeneous nuclea-
tion has been reported, so one must conclude that
the set of "critical" supersaturations reported by
Robertson and his coworkers is for heterogeneous
nucleation.
In the case of struvite, uric acid, and cystine,
published estimates of S* provide a useful criterion
for separating stone-formers from non-stone-for-
mers. Robertson's estimates of S*, however, do not
provide a reliable criterion for distinguishing formers
from non-formers of calcium oxalate and sterile cal-
cium phosphate stones. One possible explanation
being advanced for this failure is that the urine of
stone-formers contains more heterogeneous nucleat-
ing particles than that of non-stone-formers [361. A
few workers [36—391 have investigated Lonsdale's
suggestion [24] that various stone salts could act as
coherent heterogeneous nucleation catalysts for
other stone salts. These workers have shown that
given sufficient supersaturation and appropriate pH,
brushite, hydroxyapatite, whewellite, and monoso-
dium urate will nucleate each other. Inasmuch as the
maximal supersaturation relief in 30 mm in the sys-
tems that were studied was 20% or less, it is not clear
how relevant these observations are to the biologic
problem of urolithiasis. Transit time across a kidney
is < 10 mm (i.e., volume/flow rate). With data pre-
sented by Pak, Hayashi, and Arnold [37], one can
calculate that a 20% solution depletion in 30 mm
implies a linear growth rate of less than 1.6 nm/mm,
if all the particles in the test system are growing at
the same rate. To make this calculation, we use the
relation
/\ 3 / \112' I2\
's\L) )' (31)
(30) in which 1 is a characteristic length and m is a mass ofparticles. The densities of stone particles are all —2,
so it is not necessary to calculate rim growth. Fur-
thermore, we have assumed that the average particle
size is 10 nm; a smaller particle would imply a lower
growth rate. In view of the transit times, a worst-
case growth rate of 1.6 nm/mm does not constitute a
serious health hazard. If only a few particles nucleate
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in the in vitro heterogeneous nucleation systems,
however, then the implied growth rate would be far
greater, perhaps even significant. Particle size distri-
bution in these systems was not analyzed, so the
biologic significance of in vitro heterogeneous nu-
cleation with respect to urinary stone salts would
recognize that total growth is the convolution of
nucleation and growth. Given the experimental ob-
servation of solution depletion and a valid growth-
rate law, the nucleation rate can be readily separated
from the growth rate with Laplace transforms [401.
The data published thus far do not merit such a
detailed analysis.
Particle growth
The detailed growth history of a urinary stone is
unknown. From an investigative point of view, per-
haps the most informative studies have been on the
rate of particle growth of precipitates in urine. If the
product of particle growth rate and particle transit
time is small, relative to the diameter of lumen
through which the growing particle must pass, then
the particle will be passed harmlessly and will not
develop into a macroscopic stone. In particle-growth
studies, a distinction must be made between crystal
growth and growth by aggregation. A slurry of crys-
tals in a supersaturated solution will increase in size
and under appropriate conditions will aggregate, in
which case the particle size distribution is not the
same as the crystal size distribution. Urinary stones
are typically polyciystalline masses [261, and the
particle size distribution in urinary stones is not iden-
tical with the crystal size distribution. Even the crys-
talluric particles from a stone-former are polycrystal-
line [41], and it follows that the crystalluric particle
size distribution does not equal the crystal size distri-
bution. It is necessary to understand the kinetics of
the particle size distributions that occur in urine if we
are to understand how urinary stones form. We are
just beginning to develop an understanding of urinary
stone crystal growth and aggregation mechanisms.
What little work is being done usually does not dis-
tinguish between the two mechanisms. There are at
least five methods for studying crystal growth, as
described below.
Single crystals. Single-crystal studies have the ad-
vantage that aggregation is not a problem; therefore,
growth measurements can be made on individual
faces. However, single-crystal studies have not been
done yet on stone crystals.
Spontaneous precipitation. In spontaneous-pre-
cipitation studies, an unstable supersaturated solu-
tion is allowed to precipitate spontaneously. To dis-
tinguish between crystal growth and aggregation, it is
necessary to use two independent monitoring meth-
ods. It is convenient to observe the early part of the
reaction by measuring solution depletion with elec-
tric conductivity and by measuring particle size dis-
tribution with light-scattering. As the reaction goes
toward completion, wet chemical methods of mea-
suring solution depletion and Coulter counter meth-
ods of particle size distribution analysis are often
more convenient. Doremus, Gardner, and McKay
[42] have used spontaneous precipitation to study
growth of stone-salt particles. They observed that
the order of the growth reaction for calcium oxalate
is 3 when A1/A0 5. They noted that other workers
had observed that the order of the reaction at lower
supersaturations is 2 [43]. The growth equation Do-
remus et al used to analyze their data is
(dW/dt) = kb(1 — W), (32)
in which k is a growth constant, b is a system param-
eter, W is the extent of reaction, and n is the order of
the reaction [421. One potential problem with Equa-
tion 32 is that it does not explicitly account for
change in particle surface area, which in the sponta-
neous precipitation, undergoes considerable change
in the early part of the reaction. In this case, one
might expect the equation of Johnson and O'Rourke
[44] to be more appropriate:
(dW/dt) = kb°(i — W), (33)
in which b is now a function of W, and q is an
empirical constant that is usually 2/3• This equation,
by accounting for changing surface area, might pro-
vide a concordance between high- and low-supersa-
turation growth-rate reaction orders. Nielsen [351
reported that calcium oxalate in spontaneous precipi-
tation does follow Equation 33, but could not decide
whether n was 3 or 4. In their study of spontaneous
precipitation of calcium oxalate, Doremus, Gardner,
and McKay reported that the initial precipitate is
CaC2O4 3H20, which undergoes solid-state transfor-
mation with an activation energy of 45 kcallmole
(relaxation time, —--4 hr at 37°C) [42]. Voided calcium
oxalate particles ordinarily are CaC2O4 H20 (whew-
ellite) or CaC2O4 2H20 (weddellite). It is of consid-
erable interest to know what the crystal is when
urine is leaving the renal papillae during calcium
oxalate crystalluria. It is hoped that such information
will soon be available.
Füredi-Milhofer et al [45] have observed that burst
precipitations of brushite also follow Equation 33,
with q = 2/3 and n = 2, except that in this case the
independent variable W was the reacting ion concen-
tration product.
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The concept of a formation product and sponta-
neous precipitation. This section digresses from the
discussion of crystal growth mechanisms in order to
comment about the use of spontaneous precipitation
in studying formation products. A formation product
is the minimum ion activity product needed to induce
a salt to precipitate. It should be clear from the
preceding discussion that a formation product is an
expression of a metastable limit. Some investigators
have attempted to estimate the formation product by
observing the minimum concentration or ion activity
product needed to cause a spontaneous precipitation
within some arbitrarily fixed time interval. The
method of detecting onset of precipitation is also
arbitrary, inasmuch as some detection methods are
more sensitive than others. Before I attempt to draw
inferences about experimental measurements of the
formation product, it is instructive to look at some
experimental results. In my laboratory, we have in- 500
vestigated the effect of allopurinol on calcium oxa- 400
late precipitation by using a Coulter counter to mea-
sure the number (N) and the average size of particles 200-
created by a spontaneous precipitation of calcium 100-
oxalate at various initial supersaturations. As pre-
dicted in the section on classical homogeneous nu-
cleation, a plot of N vs. supersaturation (Fig. 4)
shows a sudden upswing and suggests a calcium
oxalate metastable limit for homogeneous nucleation
of S > 100. Also, as predicted, a plot of the average
particle diameter vs. relative supersaturation (Fig. 5)
goes through a maximum located between a relative
supersaturation of 80 and 100, which suggests that
the metastable limit for homogeneous nucleation is _______________
80. Previous estimates in the urolithiasis literature
of the metastable limit for homogeneous nucleation
_______________
of calcium oxalate have never exceeded a relative
supersaturation of 11 [191. Using an approach like
the one outlined for Figure 5, Walton [20] reported
that the homogeneous nucleation metastable limit for
calcium oxalate at 25°C is a relative supersaturation
of 30.
Inasmuch as Figures 4 and 5 indicate that particles
are nucleating at initial supersaturations less than the
metastable limit, heterogeneous nucleation also oc-
curs in the systems described by Figures 4 and 5. The
information presented in the section on classical nu-
cleation suggests that when both homogeneous and
heterogeneous processes occur, the rate of nuclei
formation (JB) should be written
JB = F exp(—4(f(O)1cr3Z)) (34)
• No allopurinol
• 1 m allopurinol
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Fig. 4. A plot offinal numbers of calcium oxalate particles per ml
resulting from a burst of precipitation vs. log10 (initial relative
supersaturation). The number of particles is taken to be the num-
ber of nucleation events (pH, 6.5; temperature, 38°C).
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Fig. 5. A plot of mean particle diameter vs. log10 (initial relative
where Z = (lnSY2, i = I is the homogeneous case in supersaturation). Conditions are the same as in Figure 4.
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which f(O)1 = 1, and all the other n — 1 cases are
heterogeneous nucleations with (1 — f(O)1) indicating
the catalytic efficiency of the th class of heteroge-
neous nucleating site. The relation between Equation
34 and the Coulter counter measurements in Figure 4
is
N = f JBdt. (35)
The difficulty with integrating Equation 35 is that
Z in Equation 34 is not available in analytic
form. If, however, (d2ZIdt2) 0 until 1
>>exp(—4)(f(8)1cr3Z)), then
N = E F exp(—4)(f(O)1&'Z))dt, (36)
fl
and N = Q' exp(—4)(f(6)1cr8Z(t = 0))) (37)
with Q = F1/(+4)cr3(dZ!dt)f(O)!) and (dQ1/dt) 0.
A transformation of the data in Figure 4 to a plot of
ln(N) vs. Z(t = 0) shown in Figure 6 strongly sug-
gests that the assumptions giving rise to Equation 37
are valid and that n = 2 (i.e., the experimental
system has only one class of heterogeneous nuclei).
Much of the information suggested by Figure 6 can
be given intuitively simple interpretations. For ex-
ample, since f(O)1 = 1, the slope of the steepest limb
of the curve is —4)o. 4) is a combination of known
physical constants; and we calculate, from Figure 6,
that a for calcium oxalate is 69 erg/cm2, which is in
excellent agreement with the reported value of 67
erg/cm2 [20]. Since the slope of the other limb of the
curve in Figure 6 is —4)af(O)2, and —4)a2 is known,
f(O)2 can be estimated. Furthermore, the intercept of
the lower limb at Z = 0 is a count of the number of
heterogeneous nuclei.
The important points to be gained from Figures 4,
5, and especially 6 are: 1) Homogeneous nucleation
of calcium oxalate in urine is most improbable. The
kidney is incapable of creating sufficient supersatura-
tion. It also follows that current methods of estimat-
ing apparent formation products measure either the
catalytic efficiency of heterogeneous nuclei or an
alteration in the liquid-solid interfacial energy of pre-
cipitating salts. 2) The catalytic efficiency (1 — f(O)1)
of heterogeneous nuclei in urine is experimentally
measurable. Nucleation inhibitors in urine can act by
altering either the calcium oxalate liquid-solid inter-
face (a) or the catalytic efficiency of heterogeneous
nuclei (f(O)1). Appropriate use of Equation 36 would
permit evaluation of both effects. 3) The number of
nuclei in urine can be measured. The point of view
developed in this section is a means of removing the
ambiguity associated with existing observations of
formation products.
I hope that the preceding discussion and Figures
4—6 make it apparent that the concept of a unique
formation product does not naturally derive from a
theoretical foundation. A criterion for selecting a
formation product is arbitrarily imposed by workers
to provide a practical means of comparing the ten-
dency to precipitate spontaneously in various urine
samples.
Seeded crystals. To study seeded-crystal growth,
seed crystals are added to a supersaturated solution,
and the reaction is monitored. Nancollas and Gard-
ner [43] and Marshall and Nancollas [46] have ex-
ploited the seeded-crystal growth system for whew-
elite and brushite. By experimental design, the
surface-area change in the whewellite system was
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Fig. 6. A transjbrmation of dolt: in Figure 4: The nuturul logo-
rithm ofthefiualpurticle couceutrution vs. (ln(relative supersutur-
ution))2. The presence or absence of allopurinol is suppressed.
The circles are experimental data. The solid line is a least squares
fit of Equation 37 with n = 2.
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small, and, using Equation 32, they observed that n
= 2. However, in the analysis of the brushite experi-
ments, the reaction variable, W, in Equation 32 was
the reacting ion concentration product. Again, it was
found that n = 2. In seeded crystal growth experi-
ments, Meyer and Smith [47] measured the linear-
growth-rate constant for whewellite with Equation
32 and with n = 2 at —0.2 j.tm!min at urine concentra-
tions of calcium and oxalate. (The method for trans-
posing the rate constants in Equations 32 and 33 is
presented elsewhere [48].) Because of growth inhibi-
tors in urine, the growth rate is expected to be much
smaller in urine than the value found in uninhibited
simple solutions.
In our laboratory, working with seeded whewellite
crystals, we have been unable to fit our data to
Equation 32 with the reaction variable W being activ-
ity or concentration of either reactant, in contrast
with the experience of Meyer and Smith [47] and
Nancollas and Gardner [431. Our systems, however,
examine a larger range of supersaturation, a larger
surface-area variation, and a larger extent of reaction
than those of the other workers. We found that if A1!
A0 is the reaction variable in Equation 32, good fits
are obtained (Fig. 7), but the calculated surface-
normalized rate constants have ratios approximating
the ratios of the initial reacting surface. Therefore, it
appears that an equation like Equation 33 should be
used in the analysis. Because of the difficulty in
integrating Equation 33, workers have used the dif-
ferential form of the equation or tables of numeri-
cally integrated values. If a linear approximation is
made of the b213 term in Equation 33, the error is
<5% if the final crystal weight is not greater than
twice the initial crystal weight. This approximation is
done as follows: with S = A1!A0, we write
dS!dt =
—Ks(S — 1)2, (38)
with K the growth-rate constant and s the surface
area. Equation 38 is readily transformed into Equa-
tion 33. Note that with uniform growth,
v1 2/3
ssI(j) (39)
in which the subscript I indicates the initial value,
and M is crystal mass. We note further that
M/M1 = 1 + (zM1M1). (40)
M is approximated by
Q(S1 — S). (41)
Fig. 7. Seeded crystal growth rate data plotted in the integralform
of Equation 32 with n = 2. Solid lines are least squares fits. Either
16 or 32 mg of calcium oxalate seed crystals were used. The total
system citrate concentration, when added was 50 M (tempera-
ture, 38°C: pH, 6.5; and stining, 600 rpm).
With Q a constant of proportionality,
Q = AM'/(S1 — 1), (42)
with M* being the maximal possible increase in
crystal weight. Therefore,
/ M'\ 2/3 / /M*\ / S — S\ \ 2/3) =l+___)))
A second linear approximation results in
( M'\21 2/M*\ /S1 —
= l+---) -
= 1 + V(S — 5),
(43)
(44)
(45)
with V defined by Equation 44. We further simplify
with
(46)
with 0 = 1 + VS1. Thus,
dS/dt =
—Ks1(0 — VS)(S — 1)2, (47)
which is readily transformed to
[(V2)
1
(V)
S
—Ks1dt— — + —z 0—VS (S 1)2
O—2V/ S
+ (S— l)2)]dS (48)
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in which = (V — 0)2. Equation 48 is readily inte-
grated to
—Ks1t = [ (-J) ln(0 — VS) + [(1)
1 (0—2V)f —l
+ln(S_1)]+
+ constant,
= G(S) + constant.
A plot of G(S) against r for a seeded-growth experi-
ment is shown in Figure 8. Plots of zS against C are
linear for both our experimental system and for four
random urine samples that we checked by ab initio
calculation. This validates the first approximation
that was used (i.e., Equation 41) and substantiates
the estimated maximal error. Thus, from Figure 10 it
appears that we have a growth law valid over reason-
able ranges of concentration and surface-area change
in a convenient integrated form. Of course, Equation
49 requires additional experimental verification.
Seeded-crystal growth studies have been done
with hydroxyapatite crystals [491. Depending on the
concentration, however, one or more phases other
(0
0
4.0
3.0
2.0
1.0
than hydroxyapatite can be growing simultaneously,
and the growth curves, even in simple solutions, are
complex and difficult to quantitatively analyze. Cal-
cium phosphate precipitates adsorb a variety of in-
hibitors known to be present in urine, and the actual
growth rate of calcium phosphate in urine is a matter
of conjecture.
Continuous crystallizers. A continuous crystallizer
(49) is a well-mixed compartment that continuously re-
ceives a supersaturated solution from an inlet and
continuously or intermittently discharges its contents
through an outlet. (The urinary tract can be consid-
ered as a series of continuous crystallizers, i.e., col-
lecting duct, renal pelvis, and urinary bladder [501.)
If the volume of the crystallizer and the concentra-
tion at the inlet are constant, the crystallizer dynam-
ics are described by n = n0exp(—x/ar), in which n is
the concentration density of particles of size x, a is
the growth rate, and r is the system volume divided
by the flow rate [51]. Inasmuch as (an0) is the nuclea-
tion rate, the system simultaneously gives informa-
tion about crystal growth and nucleation rates. We
have measured a whewellite growth rate of 0.79 mI
mm with a calculated A1/A0 of 32. With a similar
input, Miller, Randolph, and Drach observed that the
growth rate of weddellite was less than 1 m!min
[52, 531.
The measurement of crystal growth rate in solu-
tions has been dealt with at some length for several
reasons. The most important is that the growth rate
gives an upper bound on the time required to form a
stone, and a firm grasp of growth rate permits us to
start speculating about what is and what is not possi-
ble with regard to mechanisms in stone disease. In
addition, with a clear understanding of how stone
crystals grow, it will be possible to increase the
sophistication of the in vitro tests done on urine to
measure the tendency to grow stones and the effec-
tiveness of antistone therapy.
Crystal growth in gels. Stone-salt crystals have
been grown in gel systems [54, 551. It is quite difficult
to measure growth rate as a function of concentra-
tion in these systems because the analysis requires a
complex diffusion calculation. However, growth in
gel systems offers the best opportunity, so far, of
growing large crystals (>100 m in diameter) of
stone salts. Gel systems typically yield crystals s I
mm.
Aggregation
Urinary stones and crystalluria particles are often
described as polycrystalline aggregates. Robertson et
al [81 are using aggregation inhibition as a factor in
their evaluation of the stone-forming potential of
5.0
32 mg of calcium
0 5 10 15 20 25 30 35 40 45 50 55 60
Time, rn/ri
Fig. 8. A plot of G(S) vs. time for seeded calcium oxalate crystal
growth. See text, Equation 49, for definition of G(S). Conditions
are the same as in Figure 7.
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urine. Although it is generally agreed that aggrega-
tion is important in urolithiasis, very little work has
been done on the details of stone-salt aggregation.
The following is an outline of the problem as it
pertains to urolithiasis.
When particles are about one centimeter in diame-
ter or larger, gravitational forces tend to be greater
than adhesional forces. But as the size of particles
diminishes, the effect of adhesion relative to gravita-
tion rapidly becomes dominant. For particles about
one micrometer in diameter, adhesional forces are
about a millions times greater than gravitational
forces [56]. Thus, in dealing with fine-particle pro-
cesses, adhesion must be taken into consideration.
In dealing with crystalluria, it appears to be neces-
sary to consider both particle-to-particle and parti-
cle-to-membrane adherence [48]. In addition, pre-
liminary measurement of stone density has shown
that stones have densities approaching the density of
stone crystals [571—very much higher than would be
expected if stones formed purely by close-packed
aggregation. Therefore, if aggregation is significant in
urolithiasis, densification of the aggregate must also
occur.
There are six basic mechanisms by which aggre-
gates are held together [561. In order of increasing
energy, they are electrostatic attraction, van der
Waal forces, liquid bridge, capillarity, viscous
binder, and solid bridge. Because there is total im-
mersion, liquid bridges and capillarity are not ex-
pected to play a large role in crystalluria particle
interaction or in urolithiasis. Because of the zeta
potential on particles immersed in urine, the electro-
static forces, if significant at all, will be repulsive. It
is expected, on the basis of protein-adsorption iso-
therms [581, that each calcium oxalate particle in
urine is coated 75% or more with a monomolecular
layer of protein that may act as a viscous binder.
Solid bridges can occur only after particle-to-particle
apposition due to other adhesive forces. Therefore,
we write in a qualitative way for particles in urine,
force of adhesion = van der Waal
— electrostatic + viscous binding (50)
For two spheres of equal size,
van der Waal = hor/16]ITat, (51)
in which hw is a tabulated function, r is the radius,
and a is the separation distance;
electrostatic = Hij2rl2a,
in which and €, have their customary electrostatic
meaning of electric permitivity, and Ja is the surface
contact potential; and
viscous binding M(8 — RTIn(k))h(a), (53)
in which M is moles of binder, 0 is the reference
energy, R is the universal gas constant, T is the
absolute temperature, k is the reciprocal of the con-
centration at which half surface saturation by the
viscous binder occurs, and h(a) is a Heaviside unit
function = 1 for a 20A.
The elements of Equation 50 are susceptible to
individual investigation. Measurements of the affin-
ity of viscous binders, e.g., proteins, for calcium
oxalate surfaces have been reported [581. These
measurements indicate that if the protein content of
urine is 10 mgldl, the surface of calcium oxalate
particles will be covered more than 50% with ad-
sorbed protein. Relating this observation to aggrega-
tion will require study of the effect of protein on
aggregation kinetics. The electrostatic contribution
of adhesion energy can be evaluated by study of the
zeta potential of stone-salt precipitates. Figure 9
schematically shows the origin of zeta potential, and
Figure 10 shows the effect of some urinary anions on
zeta potential and the ease with which surface ad-
sorption of the anions is demonstrated. The ability of
our ab initio ion-equilibrium program to compute a
two-phase equilibrium, given the total components
of a system, makes it much easier to interpret zeta-
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Fig. 9. Zeta potential as an indicator for chemical adsorption of
ions. Whewellite is normally positively charged. A) In the absence
of chemisorbed ions, a diffuse double layer of anions (—) exists
and the zeta potential is positive. B) In the presence of chemi-
sorbed anions 0 , the net charge on the surface becomes negative
52 and the counter ions are cations. The zeta potential is ameasure of the electrical potential between the layer of chemi-
sorbed ions and the diffuse double layer of counter ions. The larger
the extent of chemisorption, the more negative the zeta potential.
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Fig. 10. Effect of various ionic species on the Zeta potential of
wheivel/ite. The reversal of zeta potential by increasing amounts of
pyrophosphate, citrate, and EHDP indicates the strong adsorbabil-
ity of these ions. This effect may relate to the mechanisms of
inhibition of polyvalent anions in urine. (Unpublished work by
CURRERI, ONODA, and FINLAY50N.)
potential experiments. From the zeta potential, we
can compute surface potential (iji) with the Gouy-
Chapman equation [591. Because of the technical
difficulty of measuring zeta potentials at ionic
strength greater than 0.05, zeta potentials have yet to
be measured in urine-like solutions. We anticipate
doing it by a short extrapolative process. Van der
Waal calculations for stone-salt particles have not
been made.
It is appropriate to be skeptical about the impor-
tance of aggregation in urolithiasis or crystalluria.
Robertson et a! [81 have advanced the notion that
aggregation inhibitors are important in urolithiasis. If
aggregation occurs as a significant step in stone dis-
ease, it might be expected to occur in a manner
somewhat like a Smoluchowski agglomeration [601,
in which case,
N/N0 = 1/(1 + (t,'T)),
in which N/N0 is the fraction of particles remaining
per unit volume after time (t) and T is the time for NI
N0 = 1/2, r > 107/N0 if the unit of N0 is particles!
milliliter and the unit of r is seconds [20]. Even if the
l0 particles/ml in crystalluria reported by Robertson
[32] is in error by two orders of magnitude, the
expected aggregation would be so slow that one
could not expect appreciable aggregation by a Smo-
luchowski process. This kinetic consideration, plus
the small difference between the density of stones
and the density of crystals, raises some doubt about
the role of aggregation in urinary stone disease, and
it is hoped that this important issue will receive more
attention in the future.
Although lesions such as Randall's Plaques and
encrusting cystitis require crystals to adhere to tis-
sue, the energy of adherence has not been measured.
Inhibition of crystal growth and aggregation
A variety of molecules that occur in urine inhibit
the crystal growth and aggregation of whewellite and
apatite in simple solutions, e.g., pyrophosphate [61],
nucleoside triphosphate [62], heparin, citrate, and
EHDP [63]. As predicted by theory, zeta-potential
measurement is a good screening process to look for
surface-active urinary stone inhibitors. Whewellite
zeta-potential perturbation by pyrophosphate be-
haves as expected (Fig. 10). Citric acid also shows,
by zeta-potential perturbation, significant surface ad-
sorption on whewellite (Fig. 10). Meyer and Smith
[61] looked at inhibition of whewellite-seeded
growth by citrate. By analysis of their rate-constant
data, they concluded that citrate concentration for
half-surface coverage of whewellite is 16 tM. This
value has been confirmed in our laboratory by mea-
suring adsorption isotherms. Meyer and Smith [61]
concluded that the effect of citrate surface inhibition
was small compared with complexing in solution.
This may be incorrect for two reasons: Meyer and
Smith did not account for the possibility that citrate
causes the equilibrium concentration to be A, in-
stead of A0, and a Langmuir plot of their rate-con-
stant data gives a negative intercept. Furthermore,
the data in Figures 9 and 10 show a 39% inhibition of
the growth rate by 50 /LM citrate.
One of the major problems in evaluating urinary
inhibitors is to know how they behave in urine.
Current practice is to add an aliquot of urine to a
seeded-growth system and observe its effect on crys-
tal growth and aggregation [63]. This method does
not necessarily indicate how the inhibitor works in
undiluted urine. There can be profound dilutional
f54 effects. For example, the 100-fold dilution used byRobertson's group [64] will obscure the inhibitory
effect of citrate and pyrophosphate that is expected
on the basis of adsorption isotherm observations.
The key to predicting inhibitor effects is the concen-
tration necessary for half-surface coverage (this con-
centration is equivalent to a thermodynamic affinity).
Another problem in evaluating the effect of inhibitors
in urine is that the competitive effects of various
urinary inhibitors are unknown. Nevertheless, Rob-
ertson et al [8] have exploited the dilution approach
—5
—4 —3
Log concentration, M
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